We found Cat-S inhibition with 30 mg/kg RO5459072 from week 11–19 to be more potent than MMF in controlling spleen macrophage activation, plasma cell expansion, hypergammaglobulinemia, and anti-dsDNA-IgG production as well as the activity and chronicity indices of lupus nephritis. Here, PIMREG is linked to lupus nephritis.